- Article metrics
- Last updated: Thu, 9 May 2024 14:22:28 Z
The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study
Access & Citations
-
- 680
- Article Accesses
-
- 0
- Web of Science
-
- 0
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.